HK:7630 Stock Latest News
Company AnnouncementsIMPACT Therapeutics Reports Positive PARP Inhibitor Data at 2026 ESMO Congress1w ago7630
Company AnnouncementsIMPACT Therapeutics Wins EMA Panel Backing for Ovarian Cancer Drug Senaparib1M ago7630
Company AnnouncementsIMPACT Therapeutics Gains Access to Mainland Investors via Stock Connect1M ago7630
Company AnnouncementsIMPACT Therapeutics CEO Boosts Stake in Hong Kong–Listed Biopharma Group1M ago7630
Company AnnouncementsIMPACT Therapeutics Narrows Loss and Strikes Global Senaparib Deal2M ago7630
Company AnnouncementsIMPACT Therapeutics to Join Hang Seng Composite Index, Bolstering Market Reach2M ago7630Company AnnouncementsIMPACT Therapeutics Advances First PROTAC Candidate IMP2794 for KAT6A-Driven Cancers2M ago7630
Company AnnouncementsIMPACT Therapeutics Narrows Loss as Senaparib Commercialization Fuels Revenue Surge2M ago7630
Company AnnouncementsIMPACT Therapeutics Sets Out Governance Framework for New Audit Committee3M ago7630
Company AnnouncementsIMPACT Therapeutics Strikes EUR423.5 Million Global Senaparib Deal With Pharmanovia3M ago7630
Company AnnouncementsIMPACT Therapeutics Shareholders Back Incentive Plan and Governance Changes3M ago7630
Company AnnouncementsIMPACT Therapeutics Unveils First Dual-Payload ADC Preclinical Candidate IMP32013M ago7630Company AnnouncementsIMPACT Therapeutics Showcases PARP Pipeline Data Ahead of Expected EU Push3M ago7630
Company AnnouncementsIMPACT Therapeutics Calls Extraordinary Meeting on Share Scheme and Governance Changes3M ago7630
Company AnnouncementsIMPACT Therapeutics Plans New Share Award Scheme to Align Staff and Shareholder Interests3M ago7630- Company AnnouncementsIMPACT Therapeutics Sets Date and Shareholder Rules for 2026 Extraordinary Meeting3M ago7630
Company AnnouncementsIMPACT Therapeutics Wins Strong Shareholder Backing for AGM Resolutions and Capital Mandates4M ago7630
Company AnnouncementsIMPACT Therapeutics Ends Share Stabilization, Confirms Public Float Compliance4M ago7630
Company AnnouncementsIMPACT Therapeutics Fully Exercises Over-Allotment Option in Hong Kong Listing4M ago7630Company AnnouncementsIMPACT Therapeutics Sets 2026 AGM to Approve Reports and New Share Issuance Mandate5M ago7630


